Vertex Pharmaceuticals Inc. (VRTX)

Index: Nasdaq 100
-5.87%
-$7.12
$114.14
16:14 29/01/15

   Trade now with Barclays Stockbrokers   Trade now with Barclays Sponsored by Barclays Stockbrokers

$114.14
16:14 29/01/15
DAILY VARIATION
-5.87%
-$7.12
VOLUME
4,009,236
DATA
52 Week High
$127.30
52 Week Low
$62.44
Shares Issued
240.52m
Market Cap
$30,202.35m
RiskGrade
183
Beta
1.32
MENU

Vertex Pharmaceuticals Inc. Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -74.5% -16.3%
ROCE 0.0%
Latest F'cast
P/E -57.6 0.0
PEG 0.0 -999,999.0
Pr/Revenue 22.7 23.1
Pr/Book 20.2
Latest F'cast
Revenue -20.6% -18.5%
PBT 0.0% n/a
EPS 0.0% -216.9%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2010-12-31 143.37 -754.63 -377.00¢ -9.3 0.0 n/a n/a 0.0%
2011-12-31 1,410.63 60.44 14.00¢ 237.2 0.0 n/a n/a 0.0%
2012-12-31 1,527.04 -12.38 -50.00¢ -83.8 0.0 n/a n/a 0.0%
2013-12-31 1,211.97 -976.12 -198.00¢ -37.5 0.0 n/a n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2014-12-31 573.02 -715.94 -299.24c 0.0 n/a 0% 0.00c 0.0%
2015-12-31 1,187.92 -193.60 -79.83c 0.0 n/a 0% 0.00c 0.0%
2016-12-31 2,922.50 1,185.95 391.70c 3,353.0 n/a 0% 0.00c 0.0%

Regulatory News

No results found

Latest Sharecast News

slide to see more

Newspaper Links

No results found